Renin-angiotensin system and plasma aldosterone in Cushing's syndrome.
The renin-angiotensin system was studied in eight patients with Cushing's syndrome (four with adrenal adenoma and four with adrenal hyperplasia) and in five normal controls. Basal plasma renin activity (PRA) and aldosterone concentration (PAC) were similar in supine position among Cushing's syndrome due to adrenal adenoma (PRA; 1.0 +/- 0.3 ng/ml/h, PAC; 7.4 +/- 1.0 ng/dl, mean +/- SE), those due to adrenal hyperplasia (1.0 +/- 0.2, 6.9 +/- 0.8) and the controls (0.8 +/- 0.1, 6.4 +/- 0.4). The PRA after furosemide (1 mg/kg i.v.) and 120 min. upright posture stimulation was similar among Cushing's syndrome due to adrenal adenoma (2.2 +/- 0.7 ng/ml/h), those due to adrenal hyperplasia (2.6 +/- 1.7) and the controls (2.5 +/- 1.2). However, the PAC response after the stimulation in Cushing's syndrome due to adrenal hyperplasia (7.1 +/- 1.2 ng/dl) was significantly lower than that in the controls (17.5 +/- 2.1) (p less than 0.01), although there was no significant difference between the PAC response in Cushing's syndrome due to adrenal adenoma (12.6 +/- 1.0) and the controls. These results indicate that PAC response to furosemide and upright pasture stimulation might be suppressed in Cushing's syndrome due to adrenal hyperplasia.
D000236:Adenoma / Q000503:physiopathology; D000310:Adrenal Gland Neoplasms / Q000503:physiopathology; D000328:Adult; D000450:Aldosterone / Q000097:blood*; D000804:Angiotensin II; D002216:Captopril; D003480:Cushing Syndrome / Q000503:physiopathology*; D005260:Female; D005665:Furosemide; D006801:Humans; D008297:Male; D008875:Middle Aged; D007703:Peptidyl-Dipeptidase A / Q000097:blood; D011187:Posture; D012083:Renin / Q000097:blood; D012084:Renin-Angiotensin System
D000804:Angiotensin II; D000450:Aldosterone; D005665:Furosemide; D002216:Captopril; D007703:Peptidyl-Dipeptidase A; D012083:Renin